Gael Forterre - 01 May 2025 Form 4 Insider Report for VOLITIONRX LTD (VNRX)

Role: Chief Commercial Officer
Signature: /s/ Gael Forterre
Issuer symbol: VNRX
Transactions as of: 01 May 2025
Net transactions value: -$1,803
Form type: 4
Filing time: 05 May 2025, 16:05:30 UTC
Previous filing: 04 Mar 2025
Next filing: 03 Jun 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Forterre Gael	Chief Commercial Officer	1489 WEST WARM SPRINGS ROAD, SUITE 110, HENDERSON	/s/ Gael Forterre	05 May 2025	0001841637

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VNRX	Common Stock	Tax liability	$1,803	-3,698	-2.3%	$0.4875	159,006	01 May 2025	Direct	F1
holding	VNRX	Common Stock						5,000	01 May 2025	By Spouse
holding	VNRX	Common Stock						32,500	01 May 2025	By Armorica Partners, LLC	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 8,944 restricted stock units that were awarded in lieu of cash compensation that would otherwise have been owed to the reporting person. No shares were sold by the reporting person or VolitionRx in such transaction.
F2	These shares of common stock are managed by Armorica Partners, LLC (formerly Armori Capital Management, LLC) ("Armorica Partners"). Mr. Forterre is the managing director and sole shareholder of Armorica Partners and has voting and dispositive control over the shares held by Armorica Partners. Mr. Forterre disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Content

Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 8,944 restricted stock units that were awarded in lieu of cash compensation that would otherwise have been owed to the reporting person. No shares were sold by the reporting person or VolitionRx in such transaction.

These shares of common stock are managed by Armorica Partners, LLC (formerly Armori Capital Management, LLC) ("Armorica Partners"). Mr. Forterre is the managing director and sole shareholder of Armorica Partners and has voting and dispositive control over the shares held by Armorica Partners. Mr. Forterre disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.